| Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints E Baghbani, S Noorolyai, D Shanehbandi, A Mokhtarzadeh, ... Life Sciences 282, 119826, 2021 | 40 | 2021 |
| Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial AH Faghfouri, B Baradaran, A Khabbazi, MA Shadbad, S Papi, E Faghfuri, ... International immunopharmacology 109, 108825, 2022 | 16 | 2022 |
| The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study A Derakhshani, Z Asadzadeh, B Baradaran, H Safarpour, S Rahmani, ... Biomedicine & Pharmacotherapy 148, 112725, 2022 | 14 | 2022 |
| Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease A Hosseini, Z Babaloo, T Gharibi, N Shomali, F Marofi, V Hashemi, ... BMC Research Notes 13, 1-6, 2020 | 14 | 2020 |
| Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study E Baghbani, S Noorolyai, S Rahmani, D Shanehbandi, MA Shadbad, ... Biomedicine & Pharmacotherapy 145, 112370, 2022 | 13 | 2022 |
| The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls S Rahmani, S Noorolyai, H Ayromlou, VK Shahgoli, D Shanehbandi, ... Gene 769, 145236, 2021 | 12 | 2021 |
| Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: a double-blind, randomized placebo-controlled clinical trial AH Faghfouri, A Khabbazi, B Baradaran, Y Khajebishak, E Baghbani, ... Clinical Nutrition 41 (5), 1083-1092, 2022 | 11 | 2022 |
| Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin S Noorolyai, E Baghbani, S Mahboob, F Zargari, A Sorkhabi, P Sameti, ... Pathology-Research and Practice 240, 154194, 2022 | 6 | 2022 |
| hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy S Noorolyai, E Baghbani, S Rahmani, MA Shadbad, N Montazami, ... Pathology-Research and Practice 236, 154004, 2022 | 4 | 2022 |
| Expression pattern of long non-coding RNAs in treatment-naïve and medicated schizophrenia patients K Javidi Aghdam, B Baradaran, S Rahmani, F Manafzadeh, SG Noor Azar, ... Scientific Reports 14 (1), 27654, 2024 | | 2024 |
| Restoration of miR-451a-5p/miR-34a-5p could suppress the proliferation and migration of human breast cancer cells through Wnt/β-catenin and ERK/P-ERK signaling pathways M Khordadmehr, B Baradaran, E Baghbani, S Noorolyai, S Rahmani, ... Archives of Razi Institute 79 (2), 367, 2024 | | 2024 |
| miR-451a-5p/miR-34a-5p restoration could suppress human breast cancer cell proliferation and migration through Wnt/β-catenin and ERK/P-ERK signaling pathways F Jigari-Asl, M Khordadmehr, B Baradaran, E Baghbani, S Noorolyai, ... Archives of Razi Institute, 2023 | | 2023 |
| The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients R Dabbaghi, R Safaralizadeh, S Rahmani, N Barpour, M Hosseinpourfeizi, ... BMC Research Notes 16 (1), 273, 2023 | | 2023 |
behzad baradaranImmunology Research Center, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
